Do you have leg pain, tingling, numbness, or muscle weakness that begins in the lower back and seems to travel down the back of one or both legs?
If these symptoms are affecting your quality of life, you may be a candidate for the CLEAR Clinical Research Study.
Sciatica is a relatively common condition as we age. Between 13% and 40% of people will experience symptoms at some point in their lives. It can happen as a result of general wear and tear or due an injury to the disks that cushion the bones (vertebrae) of your lower spine.
If the symptoms of sciatica are affecting your quality of life you may be a candidate for the CLEAR Clinical Research Study. The Study is evaluating an investigational drug for the treatment of sciatica. Eligible participants may be given SP-102 by injection in the lower back.
The CLEAR Clinical Research Study is currently being conducted at treatment sites throughout the U.S. If you have been diagnosed with, or have the symptoms of sciatica, you can learn more about the CLEAR Clinical Research Study at clearbackpainstudy.com
The CASCADE Study is looking at the impact of an investigational product for people experiencing chronic low back pain associated with degenerative changes of a disc. The investigational product aims to potentially reduce pain and improve disability that results from the condition. You may be eligible to participate in this study, if you:
If you decide to take part in the CASCADE Study, your participation will last approximately 3 years. You will be required to attend the study center a number of times so that the study doctor can assess your condition and overall health. After the start of the study when you receive the investigational product, you will be required to visit after 1, 3, 6, 12, 18, 24, and 36 months.